Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Bioprocessing - Upstream & Downstream

Manufacture Bioprocessing - Upstream & Downstream

New Paradigms in Viral Safety with MilliporeSigma

| Sponsored by MilliporeSigma

It is time to rethink traditional approaches to biosafety.

Manufacture Technology and Equipment

The Future of Biopharma – Big Needs and Smart Solutions

| Günter Jagschies, Soon Jae Park

We must never forget unmet needs when developing new medicines.

Manufacture Technology and Equipment

The Innovation Awards 2019

After a vibrant year of advances in pharmaceutical development and manufacturing technologies, we present The Medicine Maker 2019 Innovation Awards.

Manufacture Bioprocessing - Upstream & Downstream

When One Size Doesn't Fit All

| Alison Porter

More complex proteins are coming down the pipe! Next-generation protein expression will require a toolbox of next-generation solutions.

Manufacture Bioprocessing - Upstream & Downstream

Next-Generation Bioprocessing and the Implications for Viral Safety

| Kathy Remington, Michael Phillips

With the focus on next generation bioprocessing, it is important that manufacturers do not forget to re-examine their approach to viral safety.

Manufacture Quality & Compliance

Trials of a Medicine Maker

Step into the design space and your life will be changed forever.

Business & Regulation Profession

Welcoming Change

| Maryam Mahdi

Tony Hitchcock discusses his career and the evolution of the gene therapy market.

Manufacture Bioprocessing - Upstream & Downstream

Trials of a Medicine Maker

Gene is excited about the hot new trend in process development...

Manufacture Bioprocessing - Upstream & Downstream

A Continuous Confidence Boost

| Gong Wei

Higher productivity, lower hold times, lower costs… continuous processing for monoclonal antibodies could offer a number of advantages.

Manufacture Bioprocessing - Upstream & Downstream

The Holistic Approach to Upstream Viral Safety (MilliporeSigma)

| Craig Jackson, Michael Cunningham

There could be significant benefits to implementing additional measures in upstream bioprocesses to prevent viral contamination.


Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register